Recent development on synthetic biological devices treating bladder cancer.

about

Recent development on synthetic biological devices treating bladder cancer.

Item

http://www.wikidata.org/entity/Q45873502

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Recent development on synthetic biological devices treating bladder cancer.

@en

Recent development on synthetic biological devices treating bladder cancer.

@nl

type

Item

label

Recent development on synthetic biological devices treating bladder cancer.

@en

Recent development on synthetic biological devices treating bladder cancer.

@nl

prefLabel

Recent development on synthetic biological devices treating bladder cancer.

@en

Recent development on synthetic biological devices treating bladder cancer.

@nl

P1476

Recent development on synthetic biological devices treating bladder cancer.

@en

P2093

Anbang He

http://www.w3.org/2001/XMLSchema#string

Weiren Huang

http://www.w3.org/2001/XMLSchema#string

Yuchen Liu

http://www.w3.org/2001/XMLSchema#string

Zhicong Chen

http://www.w3.org/2001/XMLSchema#string

Zhiming Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Synthetic therapeutic gene circuits in mammalian cells

The noncoding RNA revolution-trashing old rules to forge new ones

Synthetic biology in mammalian cells: next generation research tools and therapeutics

Global cancer statistics, 2012

Development and applications of CRISPR-Cas9 for genome engineering.

Synthetic biology: applications come of age

Directing cellular information flow via CRISPR signal conductors.

Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637.

Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637.

Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer

P304

216-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SYNBIO.2016.08.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29062946

http://www.w3.org/2001/XMLSchema#string

P932

5625735

http://www.w3.org/2001/XMLSchema#string